PGE2/EP4 antagonism enhances tumor chemosensitivity by inducing extracellular vesicle‐mediated clearance of cancer stem cells

No abstract is available for this paper.

• Publication year

  2018

• Venue

  International Journal of Cancer

• Publication date

  2018-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.31523PMID 29658109
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PGE2/EP4 Signaling Controls the Transfer of the Mammary Stem Cell State by Lipid Rafts in Extracellular Vesicles

  2017influential reference
• Transfer of Mammary Gland-forming Ability Between Mammary Basal Epithelial Cells and Mammary Luminal Cells via Extracellular Vesicles/Exosomes.

  2017cited by this paper
• Upregulation of Cyclooxygenase-2/Prostaglandin E2 (COX-2/PGE2) Pathway Member Multiple Drug Resistance-Associated Protein 4 (MRP4) and Downregulation of Prostaglandin Transporter (PGT) and 15-Prostaglandin Dehydrogenase (15-PGDH) in Triple-Negative Breast Cancer

  2016cited by this paper
• COX‐2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis

  2016cited by this paper
• Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.

  2015cited by this paper
• Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.

  2015cited by this paper
• Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update

  2014cited by this paper
• Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells.

  2013cited by this paper
• Prostaglandin E2 Increases Hematopoietic Stem Cell Survival and Accelerates Hematopoietic Recovery After Radiation Injury

  2013cited by this paper
• Bureau of Disease Prevention and Control, Ministry of Health, Beijing 100044, P. R. China

  2013cited by this paper
• Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties

  2013cited by this paper
• A randomised controlled phase II trial of pre-operative celecoxib treatment reveals anti-tumour transcriptional response in primary breast cancer

  2013cited by this paper
• Vascular COX-2 Modulates Blood Pressure and Thrombosis in Mice

  2012cited by this paper
• CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.

  2012cited by this paper
• Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model

  2012cited by this paper
• Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling.

  2012cited by this paper
• The role of cancer stem cells in relapse of solid tumors.

  2012cited by this paper
• Slug and Sox9 cooperatively determine the mammary stem cell state.

  2012cited by this paper
• Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis

  2011cited by this paper
• Basal-like molecular subtype and HER4 up-regulation and response to neoadjuvant chemotherapy in breast cancer.

  2011cited by this paper
• Molecular stratification of triple-negative breast cancers.

  2011cited by this paper
• Triple-negative breast cancer: an unmet medical need.

  2011cited by this paper
• Non-Steroidal Anti-Inflammatory Drugs and Colorectal Cancer Risk in a Large, Prospective Cohort

  2011cited by this paper
• Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression

  2011cited by this paper
• Rab27a and Rab27b control different steps of the exosome secretion pathway

  2010cited by this paper
• The secretory small GTPase Rab27B as a marker for breast cancer progression

  2010cited by this paper
• Understanding the cancer stem cell

  2010cited by this paper
• Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A–C

  2010cited by this paper
• Effect of aspirin and NSAIDs on risk and survival from colorectal cancer

  2010cited by this paper
• Cyclooxygenase-2 and Cancer Treatment: Understanding the Risk Should Be Worth the Reward

  2010cited by this paper
• Molecular stratification of triple-negative breast cancers.

  2010cited by this paper
• Eicosanoids and cancer

  2010cited by this paper
• Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

  2009cited by this paper
• ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.

  2009cited by this paper
• Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration.

  2009cited by this paper
• Enhanced Expression of Rab27A Gene by Breast Cancer Cells Promoting Invasiveness and the Metastasis Potential by Secretion of Insulin-Like Growth Factor-II

  2008cited by this paper
• Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.

  2008cited by this paper
• Prostaglandin E Receptors*

  2007cited by this paper
• Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

  2007cited by this paper
• Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

  2007cited by this paper
• Proteomic analysis of secreted exosomes.

  2007cited by this paper
• GW627368X ((N‐{2‐[4‐(4,9‐diethoxy‐1‐oxo‐1,3‐dihydro‐2H‐benzo[f]isoindol‐2‐yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist

  2006cited by this paper
• Cox-2 expression on tissue microarray of breast cancer.

  2006cited by this paper
• Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis.

  2006cited by this paper
• Drug resistance in chemotherapy for breast cancer

  2005cited by this paper
• Supplemental Data Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion

  2005cited by this paper
• Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

  2001cited by this paper
• Dietary fish oil sensitizes A549 lung xenografts to doxorubicin chemotherapy.

  2000cited by this paper
• Chemotherapy resistance in breast cancer.

  1998cited by this paper
• Cellular and Molecular Life Sciences REVIEW Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles

  year unknowncited by this paper

• Lipid Metabolism-Driven CNS Repair via Targeted EV Delivery of PAF to Neurons.

  2026cites this paper
• The paradigm-shifting roles of caspase-3 in cancer: from death towards resuscitation

  2026cites this paper
• Exosomes serve as molecular diagnostic biomarkers and carriers for tissue engineering applications

  2025cites this paper
• Advanced drug delivery platforms target cancer stem cells

  2025cites this paper
• Progression of 1,2-Dimethylhydrazine-Induced Colonic Pathological Lesions In Albino Rats: An Experimental Model

  2025cites this paper
• Detection of Cancer Stem Cells from Patient Samples

  2025cites this paper
• Exosomal non-coding RNAs: mediators of crosstalk between cancer and cancer stem cells

  2025cites this paper
• Lipid droplets provide metabolic flexibility for cancer progression

  2024cites this paper
• High‐content screening of drug combinations of an mPGES‐1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistance

  2023influential citation
• Isolation of tumor stem-like cells from primary laryngeal squamous cell carcinoma cells (FD-LS-6)

  2023cites this paper
• Role of lipid signalling in extracellular vesicles-mediated cell-to-cell communication.

  2023cites this paper
• Exosomal miRNAs and breast cancer: a complex theranostics interlink with clinical significance

  2023cites this paper
• Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis

  2022cites this paper
• The Prostaglandin E2 Pathway and Breast Cancer Stem Cells: Evidence of Increased Signaling and Potential Targeting

  2022cites this paper
• Extracellular vesicles in β cell biology: Role of lipids in vesicle biogenesis, cargo, and intercellular signaling

  2022cites this paper
• Graphene Oxide Enhances Biogenesis and Release of Exosomes in Human Ovarian Cancer Cells

  2022cites this paper
• Autophagy and Extracellular Vesicles, Connected to rabGTPase Family, Support Aggressiveness in Cancer Stem Cells

  2021cites this paper
• The Advancing Roles of Exosomes in Breast Cancer

  2021cites this paper
• Eicosanoid regulation of debris-stimulated metastasis

  2021cites this paper
• The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition

  2021cites this paper
• The Role of Cyclooxygenase-2 in Colorectal Cancer

  2020cites this paper
• COX-2 Signaling in the Tumor Microenvironment.

  2020cites this paper
• Eicosanoids in Cancer: Prostaglandin E2 Receptor 4 in Cancer Therapeutics and Immunotherapy

  2020cites this paper
• G protein-coupled receptors in cancer stem cells.

  2020cites this paper
• JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors

  2019cites this paper
• EP4 and Class III β-Tubulin Expression in Uterine Smooth Muscle Tumors: Implications for Prognosis and Treatment

  2019cites this paper
• Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3β/β-catenin signaling pathway

  2019cites this paper
• EP4 Antagonist‐Elicited Extracellular Vesicles from Mesenchymal Stem Cells Rescue Cognition/Learning Deficiencies by Restoring Brain Cellular Functions

  2019cites this paper
• Redox‐Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin‐Promoted Cancer Stemness, Metastasis, and Drug Resistance

  2019cites this paper